Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

Combination autologous stem cell transplantation with chimeric antigen receptor T-cell therapy for refractory/relapsed B-cell lymphoma: a single-arm clinical study

Autologous stem cell transplantation (ASCT) and chimeric antigen receptor T-cells (CAR-T) have been used as consolidation therapies for patients with refractory/relapsed B cell non-Hodgkin’s lymphoma (R/R B-NHL) in remission after second-line chemotherapy or salvage therapy. However, patients with d...

Full description

Saved in:
Bibliographic Details
Main Authors: Danyang Li, Rui Liu, Zhonghua Fu, Fan Yang, Lixia Ma, Yuelu Guo, Miaomiao Cao, Yang Lei, Yimeng Dou, Xuenan Zhang, Yan Gao, Bian Wei, Biping Deng, Xiaoyan Ke, Kai Hu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Immunology
Subjects:
B-NHL
CAR-T
ASCT
combination therapy
refractory/relapsed B-cell lymphoma
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1532460/full
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items